Stocks and Investing Stocks and Investing
Thu, November 2, 2023

Matt O"Brien Maintained (STAA) at Hold with Decreased Target to $40 on, Nov 2nd, 2023


Published on 2024-10-28 07:17:38 - WOPRAI, Matt O'Brien
  Print publication without navigation


Matt O"Brien of Piper Sandler, Maintained "STAAR Surgical Company" (STAA) at Hold with Decreased Target from $45 to $40 on, Nov 2nd, 2023.

Matt has made no other calls on STAA in the last 4 months.

There are 5 other peers that have a rating on STAA. Out of the 5 peers that are also analyzing STAA, 3 agree with Matt"s Rating of Hold. Following are those relevant analyst calls for the last 4 months;

Thomas Stephan of "Stifel" Maintained at Hold with Decreased Target to $40 on, Friday, September 22nd, 2023
Bruce Jackson of "Benchmark" Downgraded from Strong Buy to Hold on, Friday, September 15th, 2023
William Plovanic of "Canaccord Genuity" Downgraded from Strong Buy to Hold and Decreased Target to $48 on, Thursday, August 3rd, 2023

These are the ratings of the 2 analyists that currently disagree with Matt;

Anthony Petrone of "Mizuho" Reiterated at Strong Buy and Held Target at $65 on, Friday, September 15th, 2023
George Sellers of "Stephens & Co." Reiterated at Buy and Held Target at $57 on, Monday, August 14th, 2023

Contributing Sources